Epoxy resin refers to a kind of polymer and prepolymer that is reactive and contains epoxide groups. In the presence of catalysts, these resins either react with one another or with several co-reactants such amines, phenols, thiols, etc. These are used to increase strength, durability, chemical resistance, and adhesion. The main types of applications are paints and coatings, composites, adhesives and sealants, and other applications. Paints and coatings are used in commercial and industrial buildings such as electrical, automotive, and marine applications owing to their mechanical and protective properties, enhance concrete floor, resistance to stains, cracks, and high temperature. Paints and coatings refer to the use of suspension of polymers mixed with colour pigments to provide an aesthetic appearance and safety to the surface. The various physical forms are liquid, solid, and solution. The various types are DGBEA (bisphenol A and ECH), DGBEF (bisphenol F andECH), Novolac (formaldehyde and phenols), and Aliphatic (aliphatic alcohols), Glycidylamine (aromatic amines and ECH), other types. The various end-users are building and construction, automotive, large and heavy vehicles and railroads, general industrial, consumer goods (including sporting equipment), wind power, aerospace, marine, and other end uses. The epoxy resin market research report is one of a series of new reports from The Business Research Company that provides epoxy resin market statistics, including epoxy resin industry global market size, regional shares, competitors with an epoxy resin market share, detailed epoxy resin market segments, market trends and opportunities, and any further data you may need to thrive in the epoxy resin industry. This epoxy resin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global epoxy resin market size grew from $10.64 billion in 2022 to $11.55 billion in 2023, at a compound annual growth rate (CAGR) of 8.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The epoxy resin market size is expected to grow to $15.77 billion in 2027 at a CAGR of 8.1%. The rising demand for epoxy resin from the automotive industry is expected to propel the growth of the epoxy resin market. The automotive industry refers to the design, manufacturing, and selling of motor vehicles that uses epoxy resin to paint the body of automobiles. The use of epoxy resin as a protective coating extends the life of automobiles. According to the Organisation Internationale des Constructeurs d'Automobiles (OICA), a France-based international trade organization, in 2021, automobile production increased globally by 3%, from 77.8 million produced in 2020 to 80.14 million in 2021. An increase in the production of automobiles increases the need for epoxy resins. Therefore, the rising demand for the automotive industry drives the epoxy resin market. Product innovation is a key trend gaining popularity in the epoxy resin market going forward. Major companies operating in the epoxy resin market are focused on product innovations to strengthen their position in the market. For instance, in April 2022, Hexion Inc., a USA-based chemical manufacturer that develops chemical materials and performance resins, launched the products EPON LY Resin 1810 and EPIKURE LY Curing Agent 3801. These chemicals are used to minimize the yellowing of epoxy coating on household and commercial surfaces to improve performance, cure, lessen air emissions, and increase surface strength. In January 2021, Huntsman Corporation, a USA-based chemical manufacturing company that develops, and markets speciality chemicals, acquired Gabriel Performance Products LLC for a $250 million deal. The acquisition helps Huntsman Corporation to expand its speciality chemical product portfolio and improve its customer base and product reach in North America. Gabriel Performance Products LLC is a USA-based chemical company that manufactures resin coating and composites. Major players in the epoxy resin market are Sika AG, Olin Corporation, Huntsman International LLC, Kukdo Chemical, Aditya Birla Chemicals, 3M, Sinopec Corporation, Nan Ya Plastics Corporation, Chang Chun Group, BASF SE, Atul Ltd., Solvay SA, Covestro AG, Jiangsu Sanmu Group Co., Ltd., Jubail Chemical Industries LLC, Kolon Industries Inc., NAGASE & CO LTD., and Techstorm. Asia-Pacific was the largest region in the epoxy resin market in 2022. The regions covered in the epoxy resin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the epoxy resin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The epoxy resin market consists of sales of glycidyl or non-glycidyl epoxy resin. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global epoxy resin market is segmented - 1) By Type: DGBEA (Bisphenol A And ECH), DGBEF (Bisphenol F And ECH), Novolac (Formaldehyde And Phenols), Aliphatic (Aliphatic Alcohols), Glycidylamine (Aromatic Amines And ECH), Other Types 2) By Physical Form: Liquid, Solid, Solution 3) By Application: Paints And Coatings, Composites, Adhesives And Sealants, Other Applications 4) By End-User: Building And Construction, Automotive, Large And Heavy Vehicles And Railroads, General Industrial, Consumer Goods, Wind Power, Aerospace, Marine, Other End-Users

Tertiary amines refer to a class of amine that contains three radicals attached to three hydrocarbon groups in the molecule. They are used in creating a variety of chemicals such as cosmetics, surfactants, disinfectants, and fuel oils. Tertiary amines are used as raw materials for synthesizing quaternary ammonium salts, various chemical derivatives, replacement processes, and amino group elimination. The main types of products in tertiary amines are c-8 ta, c-10 ta, c-12 ta, c-14 ta, c-16 ta, and other products. c-8 ta refers to a clear, colorless liquid that is used as an ion-pairing agent in the quantitative estimation of thiazinamium methyl sulphate in pharmaceutical preparations. It is used to separate tetracycline, tetracycline analogs, and their potential impurities in the mobile phase. It is used in surfactants, biocides, floatation agents, corrosion inhibitors, emulsifiers, drilling materials, and other applications that are employed in cleaning products, agricultural chemicals, personal care, the petroleum industry, water treatment, plastics, pharmaceuticals, textiles and fibers, and other end-users. The tertiary amines market research report is one of a series of new reports from The Business Research Company that provides Tertiary amines market statistics, including tertiary amines industry global market size, regional shares, competitors with tertiary amines market share, detailed Tertiary amines market segments, market trends and opportunities, and any further data you may need to thrive in the tertiary amines industry. These tertiary amines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global tertiary amines market size grew from $4.59 billion in 2022 to $4.98 billion in 2023 at a compound annual growth rate (CAGR) of 8.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The tertiary amines market size is expected to grow to $6.71 billion in 2027 at a CAGR of 7.7%. The rising demand for personal care products is expected to people the growth of the tertiary amines market going forward. Personal care products refer to an item that is intended for cleaning, grooming, boosting attractiveness, or altering the physical appearance. Tertiary amines including Triethanolamine (TEA) are used in personal care products such as skin lotions, creams, cosmetics, moisturizers, eye gels, and shaving foams as pH adjusters and surfactants. For instance, in March 2022, according to a Cosmetics Europe study, a Belgium-based trade association for the cosmetics and personal care industry, it has been found that 72% of European customers see personal care products as very important in their daily lives and an average consumer uses over 7 different cosmetics and personal care products daily. Therefore, the rising demand for personal care products across the globe is driving the demand for the tertiary amines market. Product and process innovations have emerged as the key trends gaining popularity in the tertiary amines market. Major companies operating in the market are prominently focusing on innovative industry-specific products and processes to comply with the demands of newer customers. For instance, in April 2022, A research team at the University of Illinois at Urbana-Champaign discovered a new chemical reaction, called a carbon-hydrogen amination cross-coupling reaction. This enhances and accelerates the production of tertiary amines. This innovation could lead to the development of new medications to treat diseases that are currently incurable. In July 2021, Solvay, a Belgium-based chemical company acquired Bayer’s global coatings business for an undisclosed amount. With this acquisition, Solvay aims to strengthen its range of sustainable seed coating and seed enhancement products for its agricultural customers. Bayer is a Germany-based pharmaceutical and biotechnology company that uses tertiary amines in business areas including pharmaceuticals, consumer healthcare products, agricultural chemicals, seeds, and biotechnology products. Major players in the tertiary amines market are Albemarle Corporation, KLK Oleo, Kao Corporation, Eastman Chemical Company, Arkema S.A., Balaji Amines Ltd., Temix Oleo Srl, Indo Amines Ltd., Dow Chemical, BASF SE, Lonza Group AG, Tenghui Oil Chem, Dawei Chem, lbemarle Corporation, Akzo Nobel N.V., NOF CORPORATION, Evonik Industries AG, Volant-Chem Corp., Daicel Corporation, Huntsman International LLC., DuPont de Nemours Inc., and Alkyl Amines Chemicals Ltd. North America was the largest region in the tertiary amines market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tertiary amines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the tertiary amines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The tertiary amine market consists of sales of trimethyl amine and ethylenediaminetetraacetic acid (EDTA). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global tertiary amines market is segmented - 1) By Product: C-8 TA, C-10 TA, C-12 TA, C-14 TA, C-16 TA, Other Products 2) By Application: Surfactants, Biocides, Floatation Agents, Corrosion Inhibitors, Emulsifier, Drilling Material, Other Applications 3) By End-User: Cleaning Products, Agricultural Chemicals, Personal Care, Petroleum Industry, Water Treatment, Plastics, Pharmaceuticals, Textiles and Fibers, Other End-Users

Caprolactam is a mildly unpleasant-smelling, clear to milky white organic compound. Caprolactam is a crystalline cyclic amide derivative of caproic acid with a melting point of 70 °C that possesses various properties such as tensile strength, superior elasticity, chemical and oil resistance, and low moisture absorbency. Caprolactam is used for nylon 6 production. The main raw materials used in caprolactam are phenol, cyclohexane, hydroxylamine sulfate, and others. The phenol is used as BPA, a chemical that is used in container coatings, adhesives, electronic insulators, glazing, sheeting, and optical and automotive polycarbonates. Phenol can be tasted and smelled at concentrations below those that are harmful. The different applications include nylon 6 filaments, textile yarn, nylon 6 fibers, engineering plastics, printer inks, and others. The various end-users include the textile industry, automobile industry, electrical and electronics industry, and others. The caprolactam market research report is one of a series of new reports from The Business Research Company that provides caprolactam market statistics, including caprolactam industry global market size, regional shares, competitors with a caprolactam market share, detailed caprolactam market segments, market trends and opportunities, and any further data you may need to thrive in the caprolactam industry. This anomaly detection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global caprolactam market size grew from $14.72 billion in 2022 to $15.71 billion in 2023 at a compound annual growth rate (CAGR) of 6.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The caprolactam market size is expected to grow to $19.3 billion in 2027 at a CAGR of 5.3%. The growth of the automotive industry is expected to propel the growth of the caprolactam market going forward. The automotive industry comprises the companies involved in the design, manufacture, and sale of motor vehicles and related components. The shift towards fuel-efficient and environment-friendly automobiles has encouraged the use of nylon 6 in automobiles to reduce weight and fuel consumption by the vehicle. For instance, according to the India Brand Equity Foundation, commonly known as IBEF, an Indian government export promotion agency, vehicle production in India is expected to reach 22.93 million vehicles in 2022. Therefore, the growth of the automotive industry is driving the growth of the caprolactam market. Technological advancements have emerged as a key trend gaining popularity in the caprolactam market. Major companies operating in the caprolactam sector are focused on developing new technological solutions to strengthen their position in the market. For instance, in July 2021, Fibrant, a Netherlands-based chemical products and services company, marketed its caprolactam under the tradename EcoLactam, a new generation caprolactam with a reduced carbon footprint. The company will reduce its carbon footprint by over 50 percent by applying proprietary Hydranone technology. In June 2021, DIC Corporation, a Japan-based chemicals company, acquired BASF’s global pigments business, BASF Colors & Effects, for an undisclosed amount. The acquisition brings together the complementary portfolio of products, manufacturing assets, technologies, and supply chain and customer service of both companies to serve global customers and manufacture pigments, cosmetics, coatings, inks, and plastics. BASF SE is a Germany-based chemicals company. Major players in the caprolactam market are AdvanSix Inc., Alpek S.A.B. de C.V., The Aquafil Group, Toray Industries Inc., Capro Corp., China Petrochemical Development Corporation, Domo Chemicals GmbH, Grupa Azoty Zaklady Chemiczne, Gujarat State Fertilizers & Chemicals Limited, Guangdong Highsun Grou, Zhejiang Hengyi Group Co. Ltd., KuibyshevAzot PJSC, Lanxess AG, Luxi Chemical Group Co. Ltd., China Petroleum & Chemical Corporation, Spolana s.r.o, Sumitomo Chemical Co. Ltd., Shandong Haili Chemical Industry Co. Ltd., Ube Industries Ltd., Honeywell International Inc., and Royal DSM N.V. Asia-Pacific was the largest region in the caprolactam market in 2022. North America was the second-largest region in the caprolactam market. The regions covered in the caprolactam market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the caprolactam market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The caprolactam market consists of sales of caprolactam synthesized from raw materials such as benzene and ammonia. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global caprolactam market is segmented - 1) By Raw Material: Phenol, Cyclohexane, Hydroxylamine Sulfate, Other Raw Materials 2) By Application: Nylon 6 Filaments, Textile Yarn, Nylon 6 Fibers, Engineering Plastics, Printer Inks, Other Applications 3) By End-User: Textile Industry, Automobile Industry, Electrical And Electronics Industry, Other End-Users

The antiemetics and antinauseants refer to drugs that are used in the prophylaxis or management of vomiting that results from emetogenic chemotherapy, and for the management of postoperative nausea and vomiting. Antiemetic and antinauseant drugs prevent, control, or treat, nausea and vomiting caused in general or by other medications, frequent motion sickness, infections, stomach flu, or chemotherapy. These drugs reduced the symptoms of nausea or vomiting by blocking signal messages to the part of the brain that controls nausea and vomiting. The main types of drugs in antiemetics and antinauseants are dopamine antagonists, nk1 receptor antagonists, antihistamines (h1 histamine receptor antagonists), cannabinoids, and benzodiazepines, anticholinergics, steroids, 5-ht3 receptor antagonists, and others. A dopamine antagonist also referred to as an anti-dopaminergic or a dopamine receptor antagonist, is a medication that works by blocking dopamine receptors. It is used in chemotherapy, motion sickness, gastroenteritis, general anesthetics, opioid analgesics, dizziness, pregnancy, food poisoning, emotional stress, and others and is implemented in various sectors such as hospitals, medical centers, clinics, and research institutes. The antiemetics and antinauseants market research report are one of a series of new reports from The Business Research Company that provides antiemetics and antinauseants market statistics, including antiemetics and antinauseants industry global market size, regional shares, competitors with antiemetics and antinauseants market share, detailed antiemetics and antinauseants market segments, market trends and opportunities, and any further data you may need to thrive in the antiemetics and antinauseants industry. This antiemetics and antinauseants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global antiemetics and antinauseants market size will grow from $7.76 billion in 2022 to $8.09 billion in 2023 at a compound annual growth rate (CAGR) of 4.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global antiemetics and antinauseants market size is expected to grow to $9.12 billion in 2027 at a CAGR of 3.0%. The antiemetics and antinauseants market is driven by the increase in the prevalence rate of cancer. Chemotherapy is one of the most recommended treatments to cure cancer, and chemotherapy-induced nausea and vomiting (CINV) are some of the side effects of the treatment. Antiemetics can help prevent CINV in about 60%-70% of patients. According to the WHO reports, the incidence of cancer globally has risen to 18.1 million new cases and 9.6 million deaths. According to another report by the Centers for Disease Control and Prevention, about 650,000 cancer patients in the USA receive chemotherapy in an outpatient oncology clinic each year. The CINV caused by chemotherapy treatments is cured by using antiemetic and antinauseant drugs like Dolasetron (Anzemet), Ranitidine (Zantac), and other serotonin 5-HT3 receptor types of antagonists. An increase in the incidence of cancer will increase demand for antiemetics and antinauseants, thereby driving revenue for the market. Lack of awareness about the variety of antiemetic and antinauseant drugs that are available in the market among the practitioners restrains the market. Despite the presence of a range of drugs, the practitioners prescribe similar drugs to treat patients with different conditions of nausea. The popularity of only a few drugs leads to lower demand for other drugs and thus restricts the overall growth of this market. For example, the American Society of Clinical Oncology released its first guideline in the ‘Choosing Wisely’ (CW) campaign to prevent and discourage the overuse of expensive and similar kinds of antiemetic drugs for all ailments. Manufacturers are exploiting nanotechnology in the antiemetics and antinauseants market to deliver therapeutic agents to specifically targeted sites in a controlled manner through Nanomedicine and Nano delivery systems. Nanomedicine is the medical application of nanotechnology which uses nanoparticles to enhance the action of the drug in treatment and nanotechnology is the design, characterization, production, and application of devices, structures, and systems by controlled manipulation of size and shape at the nanometer scale. The antiemetic and antinauseant drug manufacturers are inclining more toward the use of Nanomedicine or Nano drugs to make the drug effective and increase their revenues. For instance, Merck & Co., an American multinational pharmaceutical company manufactured Aprepitant under the brand name Emend. It is the first FDA-approved drug for the prevention of acute chemotherapy-induced nausea and vomiting (CINV) that uses nanotechnology to increase the absorption of the drug more easily and efficiently. The antiemetics and antinauseants market is regulated by government agencies such as US Food and Drug Administration. In the USA, title 21 of the Food and Drug Administration Department of Health and Human Services, U.S. part 336, contains conditions that all Antiemetic and Antinauseant drugs are required to fulfil to remain in the market, such as definitions, regulations, and regulations related to the labelling of the antiemetic drug products. Major players in the antiemetics and antinauseants market are Johnson & Johnson, Sanofi-Aventis, Pfizer, GlaxoSmithKline, Abbott Laboratories, Eli Lilly and Company, Merck, Eisai, Bristol-Myers Squibb, and SRS Pharmaceuticals. North America was the largest region in the drugs for antiemetics and antinauseants market in 2022. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market. The regions covered in the global antiemetics and antinauseants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the antiemetics and antinauseants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The antimetics and antinauseants market consists of sales of dopamine, serotonin, neurokinin, histamine, and acetylcholine. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global antiemetics and antinauseants market is segmented - 1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types 2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anaesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types 3) By End Users: Hospital, Medical Center, Clinic, Research Institutes

The cold and cough preparations refer to the medications that are used to treat cold and cough. The drugs for the treatment of cold and cough act on the receptors to which the virus causing the infection gets attached, by antagonizing the action of the receptors and killing the viral infection, thereby reducing congestion by lysing the mucus and dilating the bronchioles constricted by the mucus deposition. The main types of drugs in cold and cough preparations are antihistamines, expectorants, bronchodilators, decongestants, antibiotics, and others. Antihistamines are drugs or other compounds that block the physiological effects of histamine and are used to treat allergies in particular. The different types include bronchodilators, anticholinergic, and pulmonary antihypertensives. The several dosage types include oral syrups, tablets or pills, nasal drops, lozenges, and others and are distributed through various channels such as hospital pharmacies, retail pharmacies, and drug stores. The cold and cough preparations market research report is one of a series of new reports from The Business Research Company that provides cold and cough preparations market statistics, including cold and cough preparations industry global market size, regional shares, competitors with a cold and cough preparations market share, detailed cold and cough preparations market segments, market trends and opportunities, and any further data you may need to thrive in the cold and cough preparations industry. This cold and cough preparations market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global cough and cold preparations market size will grow from $66.75 billion in 2022 to $70.37 billion in 2023 at a compound annual growth rate (CAGR) of 5.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global cough and cold preparations market size is expected to grow to $84.02 billion in 2027 at a CAGR of 4.5%. The rising incidence of allergies is expected to fuel the growth of the cough and cold preparations market in the forecast period. There are many respiratory allergies such as pollen, dust, mold, and pet allergies; these allergies are caused due to contaminated outdoor and indoor air. Cough and cold preparations are consumed for treating allergies, which cause cough and cause issues in the respiratory tract. For instance, according to the European Academy of Allergy and Clinical Immunology, a non-profit organization for European clinicians, researchers, and allied health professionals, by 2025, 1 in every 3 people in the European Union is expected to be affected by allergies. Thus, the increase in the incidence of respiratory allergies will bolster the demand for cough and cold preparations, positively affecting the growth of the market. Threat from substitute products such as generic and counterfeit drugs is significantly restraining the global cold and cough preparations market. Pharmaceutical companies invest a large sum of money in the drug development process. Once a drug candidate is developed and approved by the regulatory authorities, companies patent their inventions to protect their intellectual property. During the patency period, the company holding the patent holds exclusivity for manufacturing and distribution. Post expiration of patency, generic versions of the drugs is manufactured by other companies. The prices of the generics are very low in comparison to the original brand of the drug. According to an article by Alpha InvesCo., a new FDA-approved blockbuster drug that netted $100 million a year in profit during its patent protection duration could become one that earns only $1 million a year in profit overnight after losing its patent. Additionally, there is a major international problem with counterfeit drugs. The best of these counterfeits duplicates a real drug’s formula and sells it at a lower price, which hurts pharmaceutical companies' profits. Moreover, counterfeits made with low-grade materials can destroy the reputations of legitimate products, thus affecting the growth of the market. Advancements in technologies are driving the global pharmaceutical sector including cold and cough preparations. According to a global life sciences report by Deloitte, the adoption of AI, robotic automation, the Internet of Medical Things (IoMT), blockchain, DIY diagnostics, virtual care, mobility in drug delivery and clinical trials, genomics, next-generation therapies, cloud computing, Real-World Evidence (RWE), and data-driven precision medicine are the major technologies driving the life sciences sector. AI technology is being used in diagnoses, treatment planning, patient monitoring, and drug discovery. The IoMT is allowing new business models to emerge and enhancing customer experiences. Pharmaceutical companies are also increasingly using biomarkers in the drug development process to reduce the time taken to bring the product into the market. Biomarkers are biological indicators that are objectively measured and evaluated for biological processes, pathogenic processes, or pharmacological responses to a therapeutic intervention. The cold and cough preparations market is regulated by authorities such as the Food and Drug Administration in the US. For instance, the Food and Drug Administration (FDA) restricted the use of codeine in children. Codeine is approved to treat pain and cough but this medicine carries serious risks, including slowed or difficult breathing, and can be potentially fatal. This risk is greater in children younger than 12 years but the use of codeine should also be limited in some older children. Single-ingredient codeine is FDA-approved only for use in adults. FDA is also recommending against the use of codeine in breastfeeding mothers due to possible harm to their infants. Major players in the cold and cough preparation market are AstraZeneca, Bayer, Blackmores Limited, Dabur, GlaxoSmithKline, Himalaya Global Holdings, Hyland's, Johnson & Johnson, Novartis and Perrigo Company. North America was the largest region in the cold and cough preparation market in 2022. Middle East is expected to be the fastest-growing region in the global cough and cold preparations market during the forecast period. The regions covered in the global cold and cough preparation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the cold and cough preparations market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The cold and cough preparations market consists of sales of dextromethorphan, guaifenesin, and phenylephrine. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global cough and cold preparations market is segmented - 1) By Type: Bronchodialators, Anticholinergic, Pulmonary Antihypertensives 2) By Drug Type: Antihistamines, Expectorants, Bronchodilators, Decongestants, Antibiotics, Other Types 3) By Dosage Type: Oral Syrups, Tablets/Pills, Nasal Drops, Lozenges, Other Dosage Types 4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores

Anti-asthmatic and chronic obstructive pulmonary disease refers to drugs that are used to relieve the frequency of acute attacks of asthma, emphysema, chronic bronchitis, and nocturnal awakenings. The main classes of drugs in anti-asthmatics and chronic obstructive pulmonary disease (COPD) are bronchodilators, anti-inflammatory drugs, monoclonal antibodies, and combination drugs. A bronchodilator, also known as bronchiolitis, is a drug that stimulates the bronchi and bronchioles, reducing respiratory airway resistance and boosting lung airflow. The different types include anti-histamine drugs, long-acting ß2-agonists (LABA), inhaled corticosteroids, short-acting muscarinic receptor antagonists (Samas), and other anti-asthmatics and COPD drugs (including combinations). The several end users include asthma patients, and COPD patients and are distributed through various channels such as hospital pharmacies, private clinics, drug stores, retail pharmacies, and e-commerce. The anti-asthmatics and chronic obstructive pulmonary disease (COPD) market research report are one of a series of new reports from The Business Research Company that provides anti-asthmatics and chronic obstructive pulmonary disease (COPD) market statistics, including anti-asthmatics and chronic obstructive pulmonary disease (COPD) industry global market size, regional shares, competitors with an anti-asthmatics and chronic obstructive pulmonary disease (COPD) market share, detailed anti-asthmatics and chronic obstructive pulmonary disease (COPD) market segments, market trends and opportunities, and any further data you may need to thrive in the anti-asthmatics and chronic obstructive pulmonary disease (COPD) industry. These anti-asthmatics and chronic obstructive pulmonary disease (COPD) market research report deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global anti-asthmatics and copd drugs market size will grow from $88.20 billion in 2022 to $94.10 billion in 2023 at a compound annual growth rate (CAGR) of 6.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global anti-asthmatics and copd drugs market size is expected to grow to $117.36 billion in 2027 at a CAGR of 5.7%. Modifiable risk factors including smoking, lack of physical exercise, and unhealthy eating habits drive the Asthma and COPD drugs market. Even though there is a decreasing trend in smoking prevalence globally, developing countries such as China, India, Indonesia, and Nigeria among others have increasing smoking prevalence. For instance, the number of tobacco smokers is set to increase by 24 million in Indonesia and by 7 million in Nigeria by 2025, and more than 40% of global cigarette consumption is concentrated in China. Consumption of fats including saturated fatty acids which is a risk factor for Asthma and COPD is more in high-income countries including the USA and Europe. According to WHO, in developed countries, more than 35% of total energy requirement is derived from fats when compared to <20% in low-income countries, and <25% in lower-middle-income countries. Developing the patent expiration of innovator drugs is restricting the anti-asthmatics and COPD drugs market. Due to patent expiration, generic drugs are entering the market which is inexpensive when compared to innovator drugs. For example, the patent for roflumilast tablets expired in January 2020. Daliresp, roflumilast tablets are a prescription medication meant for patients with severe COPD to reduce the number of episodes of COPD. Therefore, developing patent expiration of innovator drugs is expected to hamper the growth of the anti-asthmatics and COPD drugs market in the forecast period. The use of combination drugs for the treatment of asthma and COPD is increasing. This is due to the greater impact on patient-reported outcomes (PROs) compared to monotherapies. For example, a combination of short-acting beta-agonists (SABA) and short-acting muscarinic antagonists (SAMA) is superior compared to either medication alone in improving lung function. The use of a combination of long-acting beta-agonists (LABA), and long-acting muscarinic antagonists (LAMA) have improved lung function than long-acting monotherapy bronchodilators. Many inhalers that do not use chlorofluorocarbons (CFC) are already available for the treatment of asthma and chronic obstructive pulmonary disease. These products aren't necessarily official direct alternatives to CFC Metered Dose Inhalers, but may in many patients serve as a useful medication that could replace the need for a particular CFC Metered Dose Inhaler. FDA will determine official alternatives by using the criteria established through notice-and-comment rulemaking. Major players in the anti-asthmatics and COPD drugs market are Novartis AG, Merck & Co., GlaxoSmithKline, Boehringer Ingelheim Gmbh, AstraZeneca, Roche, Teva Pharmaceutical, Vectura, Pfizer and Abbott. North America was the largest region in the anti-asthmatics and COPD drugs market in 2022. Middle East is expected to be the fastest-growing region in the global anti-asthmatics and copd drugs market during the forecast period. The regions covered in the global anti-asthmatics and COPD drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the anti-asthmatics and COPD drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The anti-asthmatic and chronic obstructive pulmonary disease market consists of corticosteroid, bronchodilator, fluticasone and salmeterol. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global anti-asthmatics and COPD drugs market is segmented - 1) By Type: Anti-histamine Drugs, long-acting ß2-agonists (LABA), Inhaled corticosteriods, Short-acting muscarinic receptor antagonists (SAMAs), Other Anti-Asthmatics And COPD Drugs (including Combinations) 2) By Drug Class: Bronchodilators, Anti-inflammatory Drugs, Monoclonal Antibodies, Combination Drugs 3) By End User: Asthma Patients, COPD Patients 4) By Distribution Channel: Hospital Pharmacies, Private Clinics, Drug Stores, Retail Pharmacies, E-Commerce

Hindered amine light stabilizers are chemical substances with an amine functional group that are used as stabilizers in polymers and plastics. They protect polymer coatings from photo-oxidative damage by producing nitroxide radicals. The main types of hindered amine light stabilizers (HALS) are polymeric, monomeric, and oligomeric. A polymeric stabilizer is a chemical compound used to prevent the degradation of polymers. Polymeric hindered amine light stabilizers are used to safeguard the core of the material. It is used in plastics, paints and coatings, adhesives and sealants, and others, and is implemented in various verticals such as packaging, automotive, agricultural films, construction, and others. Monomeric hindered amine light stabilizers provide effective surface protection, while polymeric HALS protect the core of the material. Oligomeric hindered amine light stabilizers have excellent polymer compatibility, good extraction resistance, and good heat stability. It is highly effective in polyacetals, polyamides, polyurethanes, flexible and rigid PVC, as well as PVC blends. The hindered amine light stabilizers (HALS) market research report is one of a series of new reports from The Business Research Company that provides hindered amine light stabilizers (HALS) market statistics, including hindered amine light stabilizers (HALS) industry global market size, regional shares, competitors with a hindered amine light stabilizers (HALS) market share, detailed hindered amine light stabilizers (HALS) market segments, market trends and opportunities, and any further data you may need to thrive in the hindered amine light stabilizers (HALS) industry. This hindered amine light stabilizers (HALS) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global hindered amine light stabilizers (hals) market size grew from $1.07 billion in 2022 to $1.23 billion in 2023 at a compound annual growth rate (CAGR) of 15.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The Hindered Amine Light Stabilizers (HALS) market size is expected to grow to $2.11 billion in 2027 at a CAGR of 14.3%. The growth in the construction industry is projected to fuel the demand for hindered amine light stabilizers (HALS) over the coming years. Construction is a wide industry that involves anything from mining, quarrying, and forestry to infrastructure and building construction, product manufacturing and supply, and repair, service, and disposal. Plastics with light stabilizers and UV absorbers can handle light and heat in challenging building and construction conditions, assisting specialists in overcoming the market's difficulties. For instance, the US construction industry accounted for $2600.94 billion in 2020 and is expected to grow to $3486.93 billion by 2025 at a compound annual growth rate (CAGR) of 6.0%. The average spending of the USA construction industry is nearly $1,231 billion every year. Therefore, the growth demand for the construction industry drives the growth of the hindered amine light stabilizers market. The expansion of production facilities is a key trend shaping the hindered amine light stabilizers (HALS) market. Major players operating in the hindered amine light stabilizers (HALS) sector are focusing on production facility expansions to improve their capacity to meet rising demand from emerging markets. For instance, in April 2021, Clariant, a Switzerland-based specialty chemical company, revealed the beginning of a new world-class process and light stabilizer production facility, including hindered amine light stabilizer production. Clariant and Beijing Tiangang Auxiliary Co., Ltd. (Tiangang), a China-based manufacturer and provider of light stabilizers, jointly own this production facility. It enables Clariant and Tiangang to build on their strong partnership by enhancing their capacity to meet China's rising demand for high-process and light stabilizers from local growth sectors such as automotive, textiles, and coatings. In July 2021, Sabo S.p.A., a world leader in the development and manufacturing of hindered amine light stabilizers (HALS), entered into a partnership with SONGWON Industrial Co., Ltd. The deal will enable both organizations to maintain their leading market positions and expand opportunities outside of Europe, particularly in the areas of automotive and agricultural applications, as well as in the building and construction sector. SONGWON Industrial Co., Ltd. is based in South Korea and is the 2nd largest manufacturer of polymer stabilizers in the world for the SABOSTAB® HALS portfolio, which includes hindered amine light stabilizers (HALS). Major players in the hindered amine light stabilizers (HALS) market are ADEKA Corporation, Chitec Technology Co. Ltd., SUNSHOW, SABO S.p.A., Everlight Chemical Industrial Corp., Beijing Tiangang Auxiliary Co., Double Bond Chemical Industries Co. Ltd., Solvay, Rianlon Corporation, Clariant, Everspring Chemical Co. Ltd., TCI Chemicals, UNIQCHEM, and Lambson Limited. In 2022, Asia-Pacific was the leading region in the market for hindered amine light stabilisers market.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hindered amine light stabilizers (HALS) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the hindered amine light stabilizers (HALS) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The hindered amine light stabilizers (HALS) market consists of sales of hindered amine light stabilizer products such as HALS 770 and HALS 622. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global hindered amine light stabilizers (HALS) market is segmented - 1) By Type: Polymeric, Monomeric, and Oligomeric 2) By Application: Plastics, Paints and Coatings, Adhesives and Sealants, and Other Applications 3) By End Use Industry: Packaging, Automotive, Agriculture, Films, Construction, Other End User Industries

A modular kitchen is also referred to as modern kitchen furniture that consists of a furniture layout with modules of cabinets, which hold kitchen commodities. It facilitates the effective usage of kitchen spaces which are fitted together with symmetry to create whole functional furniture with proper segmentation. The main types of modular kitchens are floor cabinets, wall cabinets, and tall storage. Floor cabinet refers to base cabinet that generally sits on the floor and which usually gives support to the countertops. and is used for good storage, aesthetics, and for many functionalities. The various designs of a modular kitchen are L-shape, U-shape, parallel, straight, and island. Modular kitchens are made from different types of raw materials, including lacquered wood, wood sheets and melamine, metals, high-pressure laminates, and others (glass, acrylic, etc.). Modular kitchen products are sold through online and offline distribution channels. The modular kitchen market research report is one of a series of new reports from The Business Research Company that provides modular kitchen market statistics, including modular kitchen industry global market size, regional shares, competitors with a modular kitchen market share, detailed modular kitchen market segments, market trends and opportunities, and any further data you may need to thrive in the modular kitchen industry. This modular kitchen market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global modular kitchen market size grew from $22.17 billion in 2022 to $23.04 billion in 2023 at a compound annual growth rate (CAGR) of 3.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The modular kitchen market size is expected to grow to $27.34 billion in 2027 at a CAGR of 4.4%. The rapid growth in the residential construction industry is significantly contributing to the growth of the modular kitchen market. The growing number of real estate projects and the increase in demand for space-saving homes are helping the modular kitchen market grow. For instance, the US construction industry is estimated to grow by 8.7% between 2020-2025. Also, according to the US Census Bureau and the US Department of Housing and Urban Development, in December 2021, there were 1,873,000 building permits granted while the number of housing completions stood at 1,295,000. Therefore, the rapid growth in the residential construction industry is driving the modular kitchen market. Technological advancement and automation is the key trend being followed by the companies operating in the modular kitchen industry. For instance, in May 2021, RTA Outdoor Living introduced a new modular outdoor kitchen system (MOKS) that allows customers to choose designs and place ready assembled outdoor kitchen. The other concepts that are being incorporated are the introduction of technology and automation for the worktop, chimney, and other key areas such as eco-friendliness (anti-bacterial kitchens) as a key focus area of the modular kitchen. In November 2021, The TTK Prestige Company, an India-based manufacturer of kitchen appliances, and cookware, under the Prestige brand, acquired a 51% stake in Ultrafresh Modular Solutions (UMSL) for a deal amount of $4 million. This acquisition would engage in the business of modular kitchens and kitchen appliances having 85 franchise outlets across India. TTK Prestige will be able to utilize the network of Ultrafresh and enhance the reach of Prestige products in new households. Ultrafresh Modular Solutions (UMSL), is an Indian-based modular kitchens and kitchen appliances company, established in 1992. Major players in the modular kitchen market are Nobilia GB Ltd., Hafele GmbH & Co KG, Hettich Group, IFB Industries, Häcker Küchen GmbH & Co. KG, LINEADECOR, Snaidero Cucine, Bulthaup, Boston Cabinets Inc., Pedini, SieMatic, Spacewood, V3 ENGINEERS, Timbor Home, Godrej and Boyce Mfg., Lispo Total Kitchen Solution, and Meine Kuche. Europe was the largest region in the modular kitchen market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the modular kitchen report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the modular kitchen market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The modular kitchen market consists of sales of kitchen spaces, cabinets and storage spaces. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global modular kitchen market is segmented - 1) By Design: L-Shape, U-Shape, Parallel, Straight, Island 2) By Product: Floor Cabinet, Wall Cabinet, Tall Storage 3) By Raw Material: Lacquered Wood, Wood Sheets and Melamine, Metals, High-Pressure Laminates, Other Raw Materials (Glass, Acrylic) 4) By Distribution Channel: Offline (Contractors, Builders), Online